Duke University Patent Portfolio Statistics

Duke University

Duke University`s Profile

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of Duke University look like?

Total Applications:	2282
Granted Patents:	1228
Grant Index	68.83 %
Abandoned/Rejected Applications:	556 (31.17%)
In-Process Applications:	494
Average Grant Time:	3.21 Years
Average Office Actions:	1.92

Which Technology Area Duke University is filing most patents in? (Last 10 years)

Art Unit	Definition	Total Applications
1648	Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology	124
Opap	Parked GAU	95
1634	Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry	65
1652	Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes	60
1644	Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology	55

How many patents are Duke University filing every year?

Year	Total Applications
2022	1*
2021	64*
2020	126
2019	142
2018	154

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of Duke University in USPTO?

Publication number: US20210386799A1

Abstract:
In certain aspects, described herein are methods, bacteria, and compositions for the treatment of bacterial infections. Specifically, bacteria that can upregulate antimicrobial peptides, e.g., Reg3, within a subject have been identified and methods of using such bacteria to treat infections is described.

Publication date: 2021-12-16
Applicant: Duke University
Inventors: K Neeraj Surana

Publication number: US20210395342A1

Abstract:
Provided herein are peptides that exhibit ApoE biological activity, as well as compositions and pharmaceutical formulations that include the peptides. The peptides, compositions, and methods disclosed herein have broad applications as they can be used to treat a broad spectrum of injury, diseases, disorders, and clinical indications.

Publication date: 2021-12-23
Applicant: Duke University
Inventors: Dawson Hana

Publication number: US20210395754A1

Abstract:
The present disclosure provides methods and compositions for the treatment of cancer. In some aspects, the present disclosure provides splice-switching oligonucleotides that downregulate AR or EGFR expression and methods of using these splice-switching oligonucleotides to treat cancer.

Publication date: 2021-12-23
Applicant: Duke University
Inventors: Robinson Timothy

How are Duke University’s applications performing in USPTO?

Application Number	Title	Status	Art Unit	Examiner
17279386	Methods And Compositions To Treat And Prevent Infection	Application Undergoing Preexam Processing	OPAP	Central, Docket
17464168	Peptide Compounds For Suppressing Inflammation	Docketed New Case – Ready for Examination	OPAP	Central, Docket
17464474	Splice-Switching Oligonucleotides And Methods Of Use	Docketed New Case – Ready for Examination	OPAP	Central, Docket
17458019	Inhibitors Of Complement Factor H	Docketed New Case – Ready for Examination	OPAP	Central, Docket
17432011	Compositions And Methods For The Treatment Of Genetic Diseases	Sent to Classification contractor	OPAP	Central, Docket